Replicate harnesses the body’s natural protein-making power and uses synthetic biology to design unique self-replicating RNAs (srRNAs) that can direct that power to fight disease.
With our customizable srRNA platform and our diverse repertoire of virally derived vectors, we are tackling drug resistance in cancers and discovering new treatments for autoimmune and inflammatory disorders and other diseases.
Replicate is working to make srRNA therapeutics broadly accessible, to realize their promise for all patients.
Replicate srRNA vectors deliver to cells in the body an “instruction manual” for making a therapeutic protein, along with a “copying machine” to reproduce those instructions over and over so that cells continue making the protein. Using synthetic biology, we craft customized vehicles from the srRNA that are suited to deliver different kinds of therapeutic proteins.
Our srRNA approach offers exceptional advantages in therapeutic applications:
ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE SCIENCES COMPANIES.